P/E ratio for Ampio Pharmaceuticals (AMPE)

P/E ratio history for Ampio Pharmaceuticals from 2008 to 2023

PE ratio at the end of each year

P/E ratio for similar companies or competitors

Company	P/E ratio	P/E ratio differencediff.	Country
Aerie Pharmaceuticals AERI	-20.3	3,200,381.65%	🇺🇸 USA
Johnson & Johnson JNJ	11.0	-1,737,791.24%	🇺🇸 USA
Flexion Therapeutics FLXN	N/A	N/A	🇺🇸 USA
Rigel Pharmaceuticals RIGL	-114	17,914,966.42%	🇺🇸 USA
Abbott Laboratories ABT	39.5	-6,209,931.27%	🇺🇸 USA
Regeneron Pharmaceuticals REGN	19.9	-3,136,739.80%	🇺🇸 USA
Pfizer PFE	13.5	-2,126,713.36%	🇺🇸 USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.